Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
The use of GLP-1 receptor agonists in patients may prevent multiple risks.
Read More »Benefits of Using GLP-1 Receptor Agonists in Type 2 Patients
Association Between Depression and Decreased Physical Activity For T2DM Patients
Can depression affect the individual’s ability to perform any physical activity?
Read More »A Review Of Variations In Prevalence Of Diagnosed And Undiagnosed Diabetes
Could a timely diagnosis of diabetes improve management and health outcomes?
Read More »FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes, But Wait!
Unique directions for taking the pill may cause a compliance issue; it's not as simple as just taking a pill once a day.
Read More »Reversing the Metabolic Syndrome (MetS) & Preventing Type 2 Diabetes
This study discusses how restricting carbohydrates can reverse and prevent the metabolic syndrome.
Read More »EXCEED Trial: Efpeglenatide Displays Significant Reduction in HbA1c and Body Weight
Efpeglenatide, a new GLP-1 receptor agonist, referenced to liraglutide in Phase II trial.
Read More »Preventing Diabetes with Resistance Training or Aerobic Exercise
Can resistance training improve beta-cell function in patients with prediabetes?
Read More »Medications That Can Reduce The Conversion To Type 2 Diabetes
Pharmacological interventions may have a role to play in preventing progression to type 2 diabetes, but are they more important than lifestyle factors?
Read More »Sugar Substitutes and Type 2 Diabetes
A new study looks at the growing use of non-nutritive sweeteners and if they may cause, or help prevent, type 2 diabetes.
Read More »An Overview of Double Diabetes (DD)
What do we know today about patients who have double diabetes?
Read More »